Author:
Begent R.H.J.,Verhaar M.J.,Chester K.A.,Casey J.L.,Green A.J.,Napier M.P.,Hopestone L.D.,Cushen N.,Keep P.A.,Johnson C.J.,Hawkins R.E.,Hilson A.J.W.,Robson L.
Publisher
Springer Science and Business Media LLC
Subject
General Biochemistry, Genetics and Molecular Biology,General Medicine
Reference33 articles.
1. Chester, K.A. & Hawkins, R.E. Clinical issues in antibody design. Trends Biotechnol. 13, 294–300 (1995).
2. Yokota, T., Milenic, D.E., Whitlow, M. & Schlom, J. Rapid tumour penetration of a single-chain Fv and comparison with other immunoglobulin forms. Cancer Res. 52, 3402–3408 (1992).
3. Huston, J.S. et al. Protein engineering of antibody binding sites: Recovery of specific activity in an anti-digoxin single-chain Fv analogue produced in. Escherichia coll Proc Natl. Acad. Sci. USA 85, 5879–5883 (1988).
4. Colcher, D. et al. In vivo tumor targeting of a recombinant single-chain antigen-binding protein. J. Natl Cancer Inst 82, 1191–1197 (1990).
5. Milenic, D.E. et al Construction, binding properties, metabolism, and tumor targeting of a single chain Fv derived from the pancarcinoma monoclonal antibody CC49. Cancer Res. 51, 6363–6371 (1991).
Cited by
217 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献